The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression
Abstract
BACKGROUND: The efficacy, limitations, and methods of studying antidepressant treatment continued beyond initial weeks of acute major depression remain incompletely resolved. AIMS: For subjects treated in controlled trials for acute depression, we analyzed the relationship of relapse risk within 12 months of rerandomizing to placebo versus duration of initial treatment and putative stabilization. METHODS: With data from placebo arms of 45 relevant controlled trials identified in recent, systematic reviews were pooled and analyzed by regression modeling. RESULTS: There was a strong inverse correlation of shorter initial treatment and greater relapse risk after rerandomizing to placebo treatment, best fit to a power function (P ≤ 0.003); relapse risk differed by 11.4-fold, declining sharply as initial treatment continued for 16 to 20 weeks or more. CONCLUSIONS: Discontinuation of antidepressant treatment for major depressive episodes at times less than 6 months was associated with rising risks after randomization to continuation with placebo. This relationship requires critical consideration in both clinical management of depressed patients and the design and interpretation of treatment discontinuation trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We also found recently that shorter duration of initial treatment with an antidepressant, especially less than 4–6 months, is followed by higher relapse risks with a placebo (Baldessarini et al., 2015).”
From Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2016) · cites this paper as Baldessarini et al., 2015
In the citing paper
“In another study by Baldessarini et al. a strong correlation of shorter (<8 weeks) initial treatment and greater relapse risk compared with longer (≥12 weeks) initial treatment [61].”
From Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis (2021) · cites this paper as [61]
In the citing paper
“A newer meta-analysis found an exponential decrease in relapse risk with increasing treatment length (Baldessarini et al. 2015).”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Baldessarini et al. 2015
In the citing paper
“These are likely to be particularly highly correlated in the studies with shorter initial stabilization which Baldessarini et al. (2015) found to have a higher relapse rate.”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Baldessarini et al. 2015
In the citing paper
“However, this study did not compare discontinuation with maintenance and hence it is unclear how this relates to the discontinuation itself.”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Baldessarini et al. 2015
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 3×
“For this reason, it is common practice currently to continue antidepressant treatment for at least several months after apparent remission of acute depression whenever possible, and even then to discontinue treatment slowly (weeks) with close clinical monitoring for indications of impending relapse.(1,3,8) A further q…”
BackgroundSpijker, J., De Graaf, R., Bijl, R. V., Beekman, A. T. F., Ormel, J., & Nolen, W. A. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.3.208 · Cited by 514
Estimating remission from untreated major depression: a systematic review and meta-analysis
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001717 · Cited by 375
Discontinuing antidepressant treatment in major depression.
Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809003578 · Cited by 145
Self-citationIllness risk following rapid versus gradual discontinuation of antidepressants
Baldessarini, R. J., Tondo, L., Ghiani, C., & Lepri, B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060880 · Cited by 123 · cited 2×
“The present findings are not surprising, given the natural history of untreated major depressive episodes, which require a median of perhaps 12 months to recover spontaneously.(2,5,6) Indeed, the term relapse is probably appropriate for new or worsening illness arising within 12 months of the start of an acute depress…”
BackgroundThe Naturalistic Course of Unipolar Major Depression in the Absence of Somatic Therapy
Posternak, M. A., Solomon, D. A., Leon, A. C., Mueller, T. I., Shea, M. T., Endicott, J., & Keller, M. B. (2006) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000217820.33841.53 · Cited by 113 · cited 2×
“The present findings are not surprising, given the natural history of untreated major depressive episodes, which require a median of perhaps 12 months to recover spontaneously.(2,5,6) Indeed, the term relapse is probably appropriate for new or worsening illness arising within 12 months of the start of an acute depress…”
BackgroundKim, K.-H., Lee, S.-M., Paik, J.-W., & Kim, N.-S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.016 · Cited by 34
Research works printed but not linked: 1
- Borges, 2014, Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration, J Clin Psychiatry., 75, 205
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Drossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Depression in the Primary Care Setting
Park, L. T., & Zarate, C. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1712493 · Cited by 458
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
“…ECT (RR = 3.00) > MAO inhibitor (2.80) > SSRIs (2.17) ≥ SNRIs (2.10) ≥ TCAs (2.09) > various standard antidepressants (1.91) > atypical agents (gepirone, hypericum, mianserin, nefazodone, or quetiapine-ER; 1.72) > lithium (1.39), but all active agent types were significantly superior to placebo.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K.
- Affiliations
- Harvard University (US)
- National University of Singapore (SG)
- Institute of Mental Health (SG)
- Corresponding author
- Baldessarini, Ross J.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2015-02
- Volume
- 35
- Issue
- 1
- Pages
- 75-76
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2317076828
- Cited by
- 52
- References
- 7
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 1
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, antidepressant treatment duration, relapse risk, treatment discontinuation, placebo response, power function relationship
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Drug Administration Schedule, Female, Humans, Male, Recurrence, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression. https://app.cochat.ai/papers/10.1097/jcp.0000000000000263
- The paper
- Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y., & Sim, K. (2015). Duration of Initial Antidepressant Treatment and Subsequent Relapse of Major Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000263
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.